Innovators in vaginal drug delivery

Supporting miscarriage prevention and IVF treatment

Team member Ewa at work

New and innovative women-specific drug-delivery systems are required to improve patient outcomes

Learn more
Calla Lily Clinical Care' semi-automated machinery

Calla Lily Clinical Care has patented a new vaginal drug delivery device with several notable advantages

Learn more

“This device will be unbelievably popular with miscarriage patients as pessary leakage is the most frequent complaint, causing significant anxiety. The benefits of reducing psychological trauma, anxiety and depression are badly needed.”

Professor Siobhan Quenby
Director Biomedical Research Unit in Reproductive Health,
Professor of Obstetrics University of Warwick,
Deputy Director Tommy’s National Centre for Miscarriage Research,
Calla Lily Clinical Care Medical Advisor

New official UK medical guidance* recommends vaginal progesterone to reduce miscarriages

“Offer vaginal micronised progesterone 400mg twice daily to women with an intrauterine pregnancy confirmed by a scan, if they have vaginal bleeding and have previously had a miscarriage”

*NICE (UK) guideline (NG126), 24 Nov 2021 update

“Thanks to NICE’s new miscarriage management guidance, for the first time we now have a recommended medication to prescribe to help reduce the incidence of miscarriages: vaginal micronised progesterone. This new device addresses patients’ issues of leakage and inconvenience previously associated with vaginally-delivered progesterone.”

Dr Stuart Lavery
Divisional Clinical Director of Women’s Health at UCLH,
Calla Lily Clinical Care Medical Advisor

“This novel platform is of great benefit to anyone using a vaginally-delivered medication. By addressing the major issue of leakage, women can be assured the device delivers the correct dose in a convenient, tidy and less invasive fashion. It is truly a transformative device.”

Dr Kelle Moley
Former Deputy Director of Reproductive Health Technologies
at the Bill & Melinda Gates Foundation,
Calla Lily Clinical Care Medical Advisor
“The new guidance, from the health watchdog NICE, is based on research suggesting the treatment could lead to 8,450 more births each year in the UK. The more miscarriages a woman had, the more effective progesterone was, the trial found.”
BBC News, 24 November 2021

We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.